The Creoptix® WAVEsystem puts a breakthrough level of binding kinetics analysis at your fingertips by pushing the boundaries of affinity range and sample compatibility. The WAVE's exceptionally high data quality, sample compatibility and automated software facilitates drug discovery and enable new inroads into R&D.
Key features
The Creoptix® WAVEsystem combines the unrivaled high sensitivity of the GCI in the WAVEcore with the WAVEcontrol software to give you superior data analysis and the WAVEchips, our no-clog microfluidic cartridges, to support a wide range of sample types and sizes. The WAVEsystem comes with a temperature-controlled autosampler that fits vials, two 96- or one 384-well plates for further ease of use. In its entirety, the system gives you an unparalleled platform for real-time label-free binding kinetics.
Crude samples, harsh chemicals, and particles up to 1000 nm
Self-contained disposable cartridge and small footprint
Ultra-fast transition times of 150 ms with reliable determination of off-rates up to 10 s-1
Superior signal-to-noise ratios (0.01 pg/mm2 at 1 Hz)
Reliable kinetics and binding affinities (KD) from low pM to low mM with from signals below 1 pg/mm2
Analyze large ligand‑to‑analyte molecular weight ratios up to >1000:1
Up to 120 hours of unattended operation
Advantages
The Creoptix® WAVEsystem combines crude sample robustness, high sensitivity, and sophisticated software, to create a novel optical biosensor platform for real-time label-free binding kinetics.